BR0003282A - Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure - Google Patents

Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure

Info

Publication number
BR0003282A
BR0003282A BR0003282-4A BR0003282A BR0003282A BR 0003282 A BR0003282 A BR 0003282A BR 0003282 A BR0003282 A BR 0003282A BR 0003282 A BR0003282 A BR 0003282A
Authority
BR
Brazil
Prior art keywords
treatment
myocardial infarction
cardiovascular diseases
kidney failure
heart
Prior art date
Application number
BR0003282-4A
Other languages
Portuguese (pt)
Inventor
Alcebiades De Mendonca Athayde
Original Assignee
Libbs Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Libbs Farmaceutica Ltda filed Critical Libbs Farmaceutica Ltda
Priority to BR0003282-4A priority Critical patent/BR0003282A/en
Publication of BR0003282A publication Critical patent/BR0003282A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"ASSOCIAçãO FARMACêUTICA PARA TRATAMENTO DE HIPERTENSãO ARTERIAL E PREVENçãO DE DOENçAS CARDIOVASCULARES OUTRAS, COMO INFARTO DO MIOCáRDIO, ACIDENTE VASCULAR CEREBRAL E INSUFICIêNCIAS CARDìACA E RENAL". A presente invenção se refere à associação, numa mesma unidade farmacotécnica, cápsula e comprimido, mantendo-se os dois fármacos isolados fisicamente, da Amlodipina, um antagonista de cálcio, com o Ramipril, um inibidor da enzima conversora de angiotensina, ou seus respectivos sais, que é útil no tratamento da hipertensão arterial, prevenindo doenças cardiovasculares outras, como infarto do miocárdio, acidente vascular cerebral e insuficiências cardíaca e renal."PHARMACEUTICAL ASSOCIATION FOR TREATMENT OF ARTERIAL HYPERTENSION AND PREVENTION OF OTHER CARDIOVASCULAR DISEASES, LIKE MYOCARDIAL INFARCTION, CEREBRAL VASCULAR ACCIDENT AND KIDNEY FAILURE". The present invention relates to the association, in the same pharmacotechnical unit, of capsule and tablet, keeping the two drugs physically isolated, from Amlodipine, a calcium antagonist, with Ramipril, an inhibitor of the angiotensin-converting enzyme, or their respective salts , which is useful in the treatment of high blood pressure, preventing other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure.

BR0003282-4A 2000-07-14 2000-07-14 Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure BR0003282A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0003282-4A BR0003282A (en) 2000-07-14 2000-07-14 Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0003282-4A BR0003282A (en) 2000-07-14 2000-07-14 Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure

Publications (1)

Publication Number Publication Date
BR0003282A true BR0003282A (en) 2002-02-26

Family

ID=3944810

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0003282-4A BR0003282A (en) 2000-07-14 2000-07-14 Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure

Country Status (1)

Country Link
BR (1) BR0003282A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014076632A1 (en) 2012-11-15 2014-05-22 Adamed Sp. Z O.O. A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014076632A1 (en) 2012-11-15 2014-05-22 Adamed Sp. Z O.O. A pharmaceutical composition containing an ace inhibitor and a calcium channel blocker

Similar Documents

Publication Publication Date Title
Camm et al. Edoxaban: a new oral direct factor xa inhibitor
Baxter et al. Stockley's drug interactions
Gradman Rationale for triple‐combination therapy for management of high blood pressure
AU635881B2 (en) Oral anticoagulant/platelet inhibitor low dose formulation
Sood et al. Combination therapy for the management of hypertension: a review of the evidence
US20070009614A1 (en) Composition and method for treating hypertension
BR0116228A (en) Therapeutic combination of amlodipine and benazepril / benazeprilat
BG66115B1 (en) USE OF RAMIPRIL OR ITS PHARMACEUTICAL ACCEPTABLE SALT FOR PREVENTION OF CONGRESSIVE CARDIAC INCORRECT
HUP0104249A2 (en) Pharmaceutical composition for combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
Gorostidi et al. Combination therapy in hypertension
MA30779B1 (en) PEDIATRIC TABLETS OF CAPECITABINE
PL404315A1 (en) A drug and pharmaceutical composition comprising 5-hydroxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino) benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine for the treatment of severe heart failure and use thereof for the manufacture of a medicament
BR0003282A (en) Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure
Kjeldsen et al. Amlodipine and valsartan: calcium channel blockers/angiotensin II receptor blockers combination for hypertension
MacWalter et al. A benefit-risk assessment of agents used in the secondary prevention of stroke
Oparil et al. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy
Krzesinski et al. ExforgeŴ (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact
BR9905016A (en) Pharmaceutical preparation for arterial hypertension
KR20180041233A (en) A pharmaceutical composition comprising an HMG-CoA reductase inhibitor and an ECA inhibitor
Kelly et al. Efficacy and Safety of a polypill to reduce cardiovascular events: A review of clinical trials.
MacIntrye et al. Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure
Garavaglia et al. Angiotensin converting enzyme inhibitors: disparities in the mechanism of their antihypertensive effect
Sanghavi et al. Amlodipine Induced Severe Pedal Edema: A Case Report from a Tertiary Care Hospital
SAMA/Acute Coronary Syndrome Working Group Management of acute coronary syndromes clinical guideline
Scoble Renal artery stenosis as a cause of renal impairment: implications for treatment of hypertension and congestive heart failure

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM ART. 8O, 13, 24 E 25 DA LPI.

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.